Summary
doi: 10.25005/2074-0581-2015-17-3-77-82
Evaluation of methotrexate use for patients with rheumatoid arthritis during implementation of «Treat to Target» strategy in real clinical practice
Chair of Propaedeutics of Internal Diseases Avicenna TSMU
In the articleare analyzed, evaluated and presented the results of efficacy and safety of oral and parenteral methotrexate use in 57 patients with active rheumatoid arthritis (RA). Unlike to oral intake of methotrexate, parenteral its application in an adequate dose (15-20 mg / week) in combination with low doses of glucocorticoids (<10 mg / day) in patients with RA is associated with a more marked and stable clinical improvement and greater frequency of low activity and clinical remission (12,3% and 42,4%, 16,0% and 38,1%, respectively).
Thus, the use of parenteral methotrexate with rapid escalation of dose under careful monitoring of the therapy effectiveness and activity of RA and the improvement of patients’ compliance is the most important event in the practical implementation of the strategy «Treat to Target» (T2T).
Keywords: rheumatoid arthritis, methotrexate, the strategy of «Treat to Target».
Materials on the topic:
- Surgical treatment of idiopathik scared stenose of trachea
- Clinical - immunological disorders in urogenital chlamydiosis in men
- Evaluation of medication «Corvitin» in complex treatment of patients with acute myocardial infarction
- Prevalence of liver cirrhosis in Tajikistan
- Results of therapy patients in acute stage of HIV infection among prisoners
- Analysis of pregnant women morbidity, such as research microelement status of women's population living in districts of town Lipetsk with different atnropotehnogenic load
- Hormonal and metabolic concept of pathogenesis prostate diseases
- MEDICINES INFLUENCING ON REGENERATION OF PERIPHERIAL NERVES
- ABDOMINOPLASTICS IN PATIENTS WITH POSTOPERATING SCARS OF FRONT ABDOMENWALL
- PROCESS OF RECANALIZATION IN YEARLY PERIOD AFTER ACUTE TROMBOPHLEBITIS OF DEEP VEINS OF LOW EXTREMITIS